AstraZeneca’s Forxiga wins approval in China for heart failure treatment

pharmanewsdaily- February 7, 2021 0

AstraZeneca has announced that its drug, Forxiga (dapagliflozin), has received approval from the Chinese National Medical Products Administration (NMPA) to reduce the risk of cardiovascular ... Read More

AstraZeneca gets FDA breakthrough status for Farxiga in CKD

pharmanewsdaily- October 4, 2020 0

AstraZeneca has been granted breakthrough therapy designation (BTD) for Farxiga (dapagliflozin) from the US Food and Drug Administration (FDA) for the treatment of patients with ... Read More